Funding tomorrow's medical miracles
“By treating and preventing diseases at the molecular level, a new generation of doctors, clinicians, and researchers will redefine how disease, aging, and life itself are understood and experienced.”
“I believe investments in high-quality education are the best investments in improving the human condition,” said global entrepreneur and philanthropist Li Ka-shing. Recognizing the caliber of Berkeley’s research, Mr. Li chose to make a $40 million lead donation to a new 200,000-square-foot facility at the vanguard of an emerging era of scientific investigation and innovation. Named in his honor, the Li Ka Shing Center for Biomedical and Health Sciences is a nexus for multidisciplinary, cutting-edge medical research.
Professor Andrew Dillin’s laboratory is among those at the forefront of this new era. He and his team are studying genetic and molecular mechanisms that regulate aging and aging-related disease. Mutant proteins with “misfolded” structures cause such diseases as Parkinson’s, Alzheimer’s, and diabetes. The Dillin lab is looking at ways to refold the proteins while the cells are still young, preventing debilitating illnesses as we age.
Dillin’s research is supported in part by the Thomas and Stacey Siebel Distinguished Chair in Stem Cell Research, an endowed chair made possible by the campaign’s landmark Hewlett Challenge.
With its open layout, the Li Ka Shing Center fosters better collaboration and idea-sharing among the more than 450 researchers working in the light-filled and technically advanced facilities.“The most important aspect of science is communication,” says Dr. Dillin. “You’re only as good as the people around you.”